co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
Axis Direct has recommended buy rating on Divis Laboratories with a target price of Rs 1340 in its research report dated August 16, 2016.
Edelweiss is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 1430 in its research report dated August 12, 2016.
Religare is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 1260 in its research report dated May 29, 2016.
Religare is bullish on Divis Labs has recommended buy rating on the stock with a target price of Rs 1260 in its research report dated March 15, 2016
Motilal Oswal has recommended neutral rating on Divis Labs with a target price of Rs 1180 in its research report dated February 8, 2016.
Religare is bullish on Divis Labs Ind has recommended buy rating on the stock with a target price of Rs 1305 in its research report dated February 8, 2016.
ICICIdirect's is bullish on Divi‘s Laboratories and has recommended buy rating on the stock with a target of Rs 1340 in its November 02, 2015 research report.
Religare Research has come out with its report on top picks. Divis Laboratories, Asian Paints, Bharti Infratel,KPIT Technologies,Bajaj Auto, Symphony and Godrej Consumer are amongst the list.
Religare is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1305 in its October 23, 2015 research report.
ICICIdirect.com has advised to buy Divis Laboratories at Rs 1115-1135 for the target price of Rs 1350 with a stop loss of Rs 1023, in its research report dated October 5, 2015.
Emkay Global Financial Services has recommended to hold Divis Laboratories and State Bank of India (SBI) for the target price of Rs 1960 and Rs 308 respectively, in its research report dated May 25, 2015.
ICICIdirect.com has recommended to buy Divis Laboratories March Future and Colgate Palmolive March Future for target of Rs 1970 and Rs 2280 respectively, in its research report dated March 5, 2015.
Motilal Oswal has maintained a 'Neutral' rating on Divis Laboratories with a target price of Rs 1910, in its research report dated January 31, 2015.
Emkay has come out with its 11 stock picks report. The research firm has recommended to buy Jagran Prakashan, PVR, UPL, GSK Consumer; accumulate Shoppers Stop; reduce Divis Laboratories, Thermax; hold Exide Industries, NHPC and sell Punjab National Bank, JSW Energy in its research report dated February 4, 2015.
ICICIdirect.com has recommended to buy Divis Laboratories in the range of Rs 1710-1735 for the target price of Rs 2050 with a stop loss of Rs 1556, in its research report dated January 05, 2015.
Karvy has come out with its Wealth Maximizer report for 2015. "Top ten Largecap picks in the Wealth Maximizer (for a time frame of 9-12 months) are Asian Paints, Divis Lab, HDFCBank, ITC, JSWSteel, L&T, Reliance Industries, Tata Motors, TCS and Ultratech Cement" says the research firm.
ICICIdirect.com is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1795 in its August 25, 2014 research report.
ICICIdirect.com is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1633 in its August 15, 2014 research report.
Brokerage house Motilal Oswal is bullish on Grasim Industries, Divis Laboratories and has recommended to buy both the stocks with a target price of Rs 3352 and Rs 1570 respectively in its February 2014 research reports.
Brokerage house Firstcall Research is bullish on Divis Laboratories and has recommended buy rating on the stock with a target price of Rs 1253 in its December 07, 2013 research report.
Brokerage house Motilal Oswal is bullish on Indian Oil Corporation (IOCL) and Divis Laboratories and has recommended 'Buy' rating on both the stock in its research reports dated November 08, 2013, 2013.
Brokerage house Firstcall Research is bullish on Divis Laboratories and has recommended buy rating on the stock with a target price of Rs 1033 in its August 07, 2013 research report.
ICICIdirect.com is bullish on Divis Laboratories and has recommended buy rating on the stock with a target price of Rs 1191 in its research report dated August 07, 2013.
Ventura is bullish on Divis Laboratories and has recommended buy rating on the stock in its May 22, 2013 research report.
Firstcall Research has recommended hold rating on Divis Laboratories with a target of Rs 1112, in its May 21, 2013 research report.
